Australia has a vibrant healthcare, biotechnology, life sciences and medical technology ecosystem with world-class companies, research facilities and informed investors.
As part of the evolution/maturing of emerging companies, such companies may consider listing on the ASX for both commercialisation and for future growth purposes.
With over sixty-five healthcare sector listings since 2013, the ASX provides a unique platform to join an impressive peer group of both emerging and mature companies, across the pharmaceutical, medical technology, biotechnology, digital health, medical practice and pathology operations sectors.
The ASX now has sixteen listed healthcare unicorns.
In total there are 170 plus healthcare, biotechnology, medical technology & life science companies listed on the ASX, with a combined market capitalisation in excess of A$248 billion.
BlueMount Capital offers comprehensive fund raising, IPO and private placement solutions together with R&D and legal services for companies in these sectors.
Our team brings together industry experts and experienced professionals in Australia and in the USA to raise funds for your life sciences company, and support your R&D programs through Australian government incentives/programs.
Our team is ready to assist and guide you through all the business development opportunities that Australia has to offer, working side-by-side with you in meeting all challenges with our comprehensive, full-service, one-stop-shop approach to helping you reach your company’s goals and success.
